Latest Data Reinforces Effectiveness of a Potential Gene Therapy for Type 1 Spinal Muscular Atrophy
skeeze / Pixabay

Latest Data Reinforces Effectiveness of a Potential Gene Therapy for Type 1 Spinal Muscular Atrophy

According to a story from inpublic.globenewswire.com, the Novartis company AveXis has released interim data from an ongoing Phase 3 clinical trial of Zolgensma, a gene therapy drug that is being…

Continue Reading Latest Data Reinforces Effectiveness of a Potential Gene Therapy for Type 1 Spinal Muscular Atrophy
Possible Treatment for Marginal Zone Lymphoma Earns Orphan Drug Designation
GDJ / Pixabay

Possible Treatment for Marginal Zone Lymphoma Earns Orphan Drug Designation

According to a story from globenewswire.com, the biopharmaceutical company TG Therapeutics, Inc. recently made an announcement declaring that the US Food and Drug Administration (FDA) had awarded the company Orphan…

Continue Reading Possible Treatment for Marginal Zone Lymphoma Earns Orphan Drug Designation
Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C
Kapa65 / Pixabay

Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C

According to a story from Charcot-Marie-Tooth News, early preliminary testing of a possible gene therapy treatment for a certain type of Charcot-Marie-Tooth disease showed potential in a mouse model. This…

Continue Reading Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C
Research Aims to Understand the Mechanism of Neuron Death in Amyotrophic Lateral Sclerosis
kkolosov / Pixabay

Research Aims to Understand the Mechanism of Neuron Death in Amyotrophic Lateral Sclerosis

According to a story from news-medical.net, the process that causes the neurons responsible for voluntary muscle movement in amyotrophic lateral sclerosis (also known as Lou Gehrig's disease) to die is…

Continue Reading Research Aims to Understand the Mechanism of Neuron Death in Amyotrophic Lateral Sclerosis
This Phenylketonuria Patient Helped Test a Breakthrough Therapy Only to Lose Access Once the Trial Ended
source: pixabay.com

This Phenylketonuria Patient Helped Test a Breakthrough Therapy Only to Lose Access Once the Trial Ended

According to a story from BBC, Louise Moorhouse gets the nutrition that she needs through two sources: pills and foul tasting nutrient shakes. This is because she was born with…

Continue Reading This Phenylketonuria Patient Helped Test a Breakthrough Therapy Only to Lose Access Once the Trial Ended
Development of “Add-on” Therapy for Pulmonary Arterial Hypertension Ends After Poor Trial Showing
Fotorech / Pixabay

Development of “Add-on” Therapy for Pulmonary Arterial Hypertension Ends After Poor Trial Showing

According to a story from Pulmonary Hypertension News, the drug developer United Therapeutics recently issued a statement in which the company announced that it was ceasing the development of esuberaprost…

Continue Reading Development of “Add-on” Therapy for Pulmonary Arterial Hypertension Ends After Poor Trial Showing
Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis
stux / Pixabay

Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis

According to a story from AJC, three year old Reid Peteet is one of over 550 kids that have been diagnosed with acute flaccid myelitis since 2014. 2018 saw a…

Continue Reading Despite the Continued Appearance of Cases, Researchers Still Don’t Know Much About Acute Flaccid Myelitis
Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments
rawpixel / Pixabay

Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments

According to a story from CRWE World, the genetic medicines company Audentes Therapeutics has recently announced its intent to develop new therapies for myotonic dystrophy and Duchenne muscular dystrophy. These…

Continue Reading Company Announces Plans for Myotonic Dystrophy and Duchenne Muscular Dystrophy Treatments

Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis

According to a story from finanzen.at, the biotechnology company Orbsen Therapeutics recently announced that its immunotherapy product ORBCEL-C is to be tested in a multi-site clinical trial called MERLIN that…

Continue Reading Immunotherapy Drug to be Tested for Autoimmune Hepatitis and Primary Sclerosing Cholangitis
Gene Therapy Could Change Rare Disease Treatment Forever, But Will Anyone be Able to Afford It?
8385 / Pixabay

Gene Therapy Could Change Rare Disease Treatment Forever, But Will Anyone be Able to Afford It?

According to a story from BNN Bloomberg, gene therapies are without a doubt an upcoming advancement in care and treatment for many diseases that have a genetic origin. This includes…

Continue Reading Gene Therapy Could Change Rare Disease Treatment Forever, But Will Anyone be Able to Afford It?

Could a “Gene Expression Atlas” Unlock the Secrets of Amyotrophic Lateral Sclerosis?

According to a story from MD Magazine, the team at Spatial Transcriptomics has utilized an innovative computational approach in order to map gene expression on the spinal cords of patients…

Continue Reading Could a “Gene Expression Atlas” Unlock the Secrets of Amyotrophic Lateral Sclerosis?
Pulmonary Hypertension Drugs are Effective for Some Sarcoidosis Patients, Study Says
oracast / Pixabay

Pulmonary Hypertension Drugs are Effective for Some Sarcoidosis Patients, Study Says

According to a story from Pulmonary Hypertension News, many patients with the rare disease sarcoidosis frequently experience lung complications. Included in these complications is pulmonary hypertension, a condition of elevated…

Continue Reading Pulmonary Hypertension Drugs are Effective for Some Sarcoidosis Patients, Study Says